(Lys9)GLP-1 lacks insulinotropic activity but acts as a potent novel GLP-1 receptor antagonist in vivo.


Autoria(s): O'Harte, F.P.M.; Green, Brian; Gault, V.A.; Irwin, N.; Mooney, Mark; Harriott, Patrick; Greer, B.; Flatt, P.R.
Data(s)

2004

Identificador

http://pure.qub.ac.uk/portal/en/publications/lys9glp1-lacks-insulinotropic-activity-but-acts-as-a-potent-novel-glp1-receptor-antagonist-in-vivo(5cf7a10e-d506-4ac9-a178-224f39a1817e).html

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

O'Harte , F P M , Green , B , Gault , V A , Irwin , N , Mooney , M , Harriott , P , Greer , B & Flatt , P R 2004 , ' (Lys9)GLP-1 lacks insulinotropic activity but acts as a potent novel GLP-1 receptor antagonist in vivo. ' Diabetic Medicine , vol 21 , no. S2 , pp. P26 .

Tipo

article